Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients

Area of Science:

• Immunology
• Gastroenterology
• Hematology

Background:

• Active ulcerative colitis (UC) patients exhibit elevated pro-inflammatory cytokines like TNFα and IL-6 from stimulated monocytes.
• Platelets (PLTs) can modulate leukocyte inflammatory responses by forming complexes, suggesting a role in UC disease activity.

Purpose of the Study:

• To investigate the levels of monocyte-platelet complexes (CD14+PLT+) and CD162 expression in UC patients with varying disease activity.
• To determine the correlation between monocyte-platelet complexes, inflammatory markers, and endothelial cell binding.
• To elucidate the anti-inflammatory role of platelet-monocyte interactions in UC.

Main Methods:

• Flow cytometry was used to quantify circulating monocyte-platelet complexes (CD14+PLT+) and membrane CD162 expression.
• ELISA measured levels of lipopolysaccharide-binding protein, TNFα, and IL-10.
• Immunofluorescence assessed the binding of monocyte-platelet complexes to activated human umbilical vein endothelial cells (HUVECs).

Main Results:

• Patients with active UC, particularly during onset flare, showed significantly lower CD14+PLT+ levels and downregulated CD162 expression on monocytes.
• CD162 expression on monocytes inversely correlated with lipopolysaccharide-binding protein levels, indicating increased endotoxemia in active disease.
• Increased binding of CD14+PLT+ complexes to HUVECs was observed in onset flare UC patients, correlating with higher inflammatory markers.
• Platelet-monocyte co-cultures demonstrated an anti-inflammatory effect, increasing IL-10 and decreasing TNFα production, which was abrogated by blocking CD62P.

Conclusions:

• Reduced CD162 expression on monocytes in active UC patients impairs platelet binding, thereby promoting a pro-inflammatory state.
• The interaction between platelets and monocytes, mediated by CD162-CD62P, plays a crucial role in regulating inflammation in ulcerative colitis.
• Therapeutic strategies targeting platelet-monocyte interactions may offer a novel approach for managing UC flare-ups.